Effect of renin-angiotensin system inhibitors on survival in kidney transplant recipients: A systematic review and meta-analysis

Effect of renin-angiotensin system inhibitors on survival in kidney transplant recipients: A systematic review and meta-analysis

Renin-angiotensin system inhibitors, specifically angiotensin II converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB), have confirmed renoprotective benefits in patients with proteinuria and hypertension. However, it remains controversial whether these agents are beneficial...

Full description

Bibliographic Details
Main Authors:	Ya-Mei Jiang, Tu-Run Song, Yang Qiu, Jin-Peng Liu, Xian-Ding Wang, Zhong-Li Huang, Tao Lin
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Kaohsiung Journal of Medical Sciences
Subjects:	ACEI/ARB Kidney transplantation Meta-analysis Survival
Online Access:	http://www.sciencedirect.com/science/article/pii/S1607551X17301353

Similar Items

Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials
by: Chenhui Tai, et al.
Published: (2017-10-01)

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19
by: Emilia Roy-Vallejo, et al.
Published: (2021-06-01)

Targeting Renin–Angiotensin System Against Alzheimer’s Disease
by: Abadi Kahsu Gebre, et al.
Published: (2018-04-01)

Evaluation of sST-2 Role in LVH Regression Obtained in Hypertensive Mice Models After Blocking Renin-Angiotensin System
by: Lilik Yusetyani, et al.
Published: (2018-11-01)

ACEIs and ARBs and Their Correlation with COVID-19: A Review
by: Yehualashet AS, et al.
Published: (2020-09-01)

Renin-angiotensin system modulators and other risk factors in COVID-19 patients with hypertension: a Korean perspective
by: Hee-Sung Kim, et al.
Published: (2021-02-01)

Consequences of continuing renin angiotensin aldosterone system antagonists in the preoperative period: a systematic review and meta-analysis
by: Qiong Ling, et al.
Published: (2018-02-01)

Comparative efficacy of different renin angiotensin system blockade therapies in patients with IgA nephropathy: a Bayesian network meta-analysis of 17 RCTs
by: Zhihao Huo, et al.
Published: (2021-07-01)

Comparative proteinuria management of different angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for normotensive patients with CKD: a Bayesian network meta-analysis
by: Huizhen Ye, et al.
Published: (2020-03-01)

COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients
by: Sieńko J, et al.
Published: (2020-07-01)

The effect of topical ramipril and losartan cream in inhibiting scar formation
by: Bin Zheng, et al.
Published: (2019-10-01)

Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care
by: Patrick Bidulka, et al.
Published: (2020-07-01)

ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking
by: Chidinma L. Onweni, et al.
Published: (2020-07-01)

Drug Treatment of Diabetic Nephropathy on Hyperfiltration Stage
by: N.M. Skaliy
Published: (2016-02-01)

Clinical features of hypertensive patients with COVID-19 compared with a normotensive group: Single-center experience in China
by: Wang Shuang, et al.
Published: (2021-03-01)

The association of renin–angiotensin system blockades and pneumonia requiring admission in patients with COPD
by: Kim J, et al.
Published: (2016-09-01)

Efficacy and Safety of Angiotensin-Converting Enzyme Inhibitor in Combination with Angiotensin-Receptor Blocker in Chronic Kidney Disease Based on Dose: A Systematic Review and Meta-Analysis
by: Mingming Zhao, et al.
Published: (2021-05-01)

Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
by: Gian Paolo Rossi, et al.
Published: (2020-04-01)

Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients
by: Wenjun Wang, et al.
Published: (2021-01-01)

Combination therapy with SGLT2 inhibitors for diabetic kidney disease
by: Yuwen Cai, et al.
Published: (2020-07-01)

Recommendations of RAAS Blocker Use Amidst The Coronavirus Pandemic
by: Joshua Henrina, doctor, et al.
Published: (2020-05-01)

SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease
by: Honghong Zou, et al.
Published: (2017-05-01)

Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease
by: Rawan ElAbd, et al.
Published: (2021-03-01)

Coronavirus Disease-2019 Conundrum: RAS Blockade and Geriatric-Associated Neuropsychiatric Disorders
by: Aline Silva de Miranda, et al.
Published: (2020-08-01)

Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease
by: Mona A. Abdelrahman, et al.
Published: (2016-09-01)

Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria
by: Nicola Bonner, et al.
Published: (2017-05-01)

Renin–angiotensin system blockade after transcatheter aortic valve replacement (TAVR) improves intermediate survival
by: Brent Klinkhammer
Published: (2019-08-01)

The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity
by: Ahmed Ayuna, et al.
Published: (2020-09-01)

Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2
by: Tobias Zimmermann, et al.
Published: (2021-04-01)

Analysis of recipient and graft survival after primary and second kidney transplantation
by: A. V. Pinchuk, et al.
Published: (2021-07-01)

Living Donor Kidney Transplantation Improves Graft and Recipient Survival in Patients with Multiple Kidney Transplants
by: Maria Irene Bellini, et al.
Published: (2020-07-01)

Proteinuria: pathophysiology, diagnostic and therapeutic approach
by: Enrico Valvo
Published: (2013-04-01)

G protein coupled receptors of the renin-angiotensin system: new targets against breast cancer?
by: Clara eNAHMIAS, et al.
Published: (2015-02-01)

Renin–angiotensin–aldosterone system inhibitors and survival in patients with hypertension treated with immune checkpoint inhibitors
by: Drobni, Z.D, et al.
Published: (2022)

Survival after liver transplant in recipients older than 70 years: A systematic review and meta-analysis
by: Karn Wijarnpreecha, et al.
Published: (2020-01-01)

Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients
by: Theresa I. Shireman, et al.
Published: (2016-11-01)

Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19
by: Enrique Rodilla, et al.
Published: (2020-09-01)

Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL-lpr Mice
by: Maira Soto, et al.
Published: (2020-07-01)

Heart Retransplant Recipients Have Better Survival With Concurrent Kidney Transplant Than With Heart Retransplant Alone
by: Jill Savla, et al.
Published: (2015-12-01)

User of angiotensin-converting-enzyme inhibitor and/or angiotensin II receptor blocker might be associated with vascular calcification in predialysis chronic kidney disease patients: a retrospective single-center observational study
by: Kaori Takaori, et al.
Published: (2021-01-01)